News

The world’s largest financial groups are working with Nvidia to assemble a $500bn funding package for AI infrastructure development, in one of...

(Bloomberg) -- Biotech company AbCellera Biologics Inc. jumped as much as 41%, giving it a market value of almost $3 billion, after it said a potential remedy for hot flashes was effective in a mid-stage trial.Most Read from BloombergChina Unleashes $28 Trillion Capital Markets to Challenge US in AIIran Shakes Up Security Team After Saying Oman Deal ‘Very Close’Stocks Churn as Oil Advance Boosts Treasury Yields: Markets WrapTrump Amps Up Pressure on Billionaire Sargeant to Exit VenezuelaBehind B

A U.S. appeals court on Monday allowed thousands of lawsuits to move forward against Meta Platforms, Alphabet's Google, ByteDance's TikTok, and other social media companies over claims they designed their products to be addictive to young ‌users. The San Francisco-based 9th U.S. Circuit Court of Appeals rejected the companies’ bid to reverse a lower court’s ruling forcing them to ‌face some 2,400 lawsuits over the claims filed in federal court. The companies, which also include Snap Inc's Snapchat, had argued that Section 230 of the Communications Decency Act of 1996 -  which ​shields them from lawsuits over content posted by their users - also shields them from allegations that they failed to warn the public about the addictive nature of their platforms.

Boeing announced an agreement Monday to divest its air taxi and two other technology ventures to Archer Aviation for a stake in the startup.In its May earnings release, Archer said it had completed the "phase three" of the Federal Aviation Administration's four-phase certification process for its Midnight air taxi vehicle.

Embraer-Empresa Brasileira de Aeronautica (NYSE:EMBJ) said its second-quarter 2026 revenue was the highest for a second quarter in the company’s history, supported by higher aircraft deliveries, growth across its business units and continued expansion of its backlog. President and CEO Francisco Gom

SharpLink Gaming (NASDAQ:SBET) reported a wider second-quarter net loss as unrealized losses and impairment charges tied to its Ethereum holdings outweighed growing revenue from staking and yield-generating strategies. The company, which has positioned its corporate treasury around Ethereum, report

mFLUSIVA is now the first and only mRNA standalone seasonal influenza vaccine on the market, marking a major advancement for the field.

Earnings reports from Horizon Quantum and Xanadu Quantum Technologies show the companies have a chance to compete with bigger names—if they can secure capital.

According to TheFly, HSBC noted that Trade Desk is staring at an increasingly competitive operating environment across the advertising technology supply chain in the middle of AI-accelerated structural shifts away from the open web.

Initial public offerings won't unlock instant wealth for retail investors.

Revenue may disappoint, but a sharp margin rebound and record AI orders could matter more.

Berkshire Hathaway stock could have even more upside. Investors have been reacting favorably to some key aspects of the company’s second-quarter earnings report.

CPI Card Group is the bargain-priced credit card stock you've never heard of.

Cisco Faces a Major AI Test as Q4 Earnings Approach

Retailers face a more cautious back-to-school consumer who is getting fatigued by higher prices driven by inflation.

On this episode of Stock Movers: - RocketLab (RKLB) shares are higher this morning after rising Friday, following earnings from SpaceX last week. - Moderna (MRNA) shares are moving after last week's news that its mRNA flu shot won US approval in an FDA turnaround. - Intel (INTC) shares are moving after the company said it will be offering $15 billion in common stock, taking advantage of renewed interest in its business prospects during the artificial intelligence data center boom.

Shares of Super Micro Computer (NASDAQ:SMCI) are up 4% to $32.48 in Monday morning trading, leading a broad bid across AI server names heading into the company’s fiscal Q4 2026 earnings report. Hewlett Packard Enterprise (NYSE:HPE) stock is climbing 4% to $55.20, and Dell Technologies (NYSE:DELL) shares are advancing 3% to $468.67. The action is ... Super Micro Rises 4% Ahead of Earnings; HPE Gains 4%, Dell Climbs 3% as AI Server Stocks Advance

Argus Research analyst Jim Kelleher early Monday upgraded Sandisk to Buy from Hold with a 12-month price target of $1,600. Sandisk stock advanced 2.2% to $1,238.50 on Monday. At the time, Sandisk was trading around $1,757.

ACM Research's Q2 earnings and revenues beat estimates, while strong orders and new products support growth and lifted 2026 guidance.

Shares of SpaceX on Monday rose above $135, the price at which the company sold shares to the public in mid-June, for the first time since July 16.

Nvidia (NVDA) is expected to beat estimates and raise guidance on strong Vera Rubin demand and cloud

Rocket Lab stock rose slightly ahead of its earnings report on Monday. Shares rallied 27% last week.

Varex Imaging reported higher revenue, stronger non-GAAP margins and improved earnings, although tariff refunds and related customer reimbursements provided a roughly $10 million benefit to quarterly gross profit. Key Investor TakeawaysVarex Imaging (NASDAQ:VREX) reported Q3 FY2026 revenue of $211 million, up 4% year over year, with Industrial revenue reaching $77 million and Medical revenue at $134 million.

(Bloomberg) -- Global AI, a two-year-old tech firm, has raised $441 million in debt financing led by JPMorgan Chase & Co. to meet growing demand for artificial intelligence data centers.Most Read from BloombergChina Unleashes $28 Trillion Capital Markets to Challenge US in AIIran Shakes Up Security Team After Saying Oman Deal ‘Very Close’Stocks Churn as Oil Advance Boosts Treasury Yields: Markets WrapTrump Amps Up Pressure on Billionaire Sargeant to Exit VenezuelaBehind Bessent Moves, Wall Stree

Key Earnings Reports Ahead

Shares of Tenax Therapeutics and Sionna Therapeutics tumbled Monday after the biotechs revealed separate late-stage trial failures. Tenax stock fell nearly 90% after a Phase 3 trial of its experimental heart-failure pill failed to help patients walk farther than those on a placebo.

NuScale Power now has a market cap under $4 billion.

The retail investor tide may be turning on SpaceX after 59 days in the public markets.

Monday.com (MNDY) guided its third-quarter revenue below Wall Street's estimates on Monday, even as

(Bloomberg) -- Lambda Inc., an AI cloud-computing provider backed by Nvidia Corp., is selling a leveraged loan to finance a chip deal as the risky debt market becomes a new front in the borrowing binge to finance the artificial intelligence buildout. Most Read from BloombergChina Unleashes $28 Trillion Capital Markets to Challenge US in AIIran Shakes Up Security Team After Saying Oman Deal ‘Very Close’Stocks Churn as Oil Advance Boosts Treasury Yields: Markets WrapTrump Amps Up Pressure on Billi